Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study


	The anti-proliferative effects of different concentrations of RES in combination with 9.375 µM PIP against the EMT-6/Dox cell line.

Part of: AlHur MJ, Barakova N, Talib WH (2024) Combination of resveratrol and piperine to target doxorubicin resistance in breast cancer: An in vitro and in vivo study. Pharmacia 71: 1-10. https://doi.org/10.3897/pharmacia.71.e122171